CoChat

Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

Open access
Di Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., Chiurazzi, M. · 2023 · Current Nutrition Reports
Cited by 108

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Purpose of Review: Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age worldwide. This disease causes menstrual, metabolic, and biochemical abnormalities such as hyperandrogenism, oligo-anovulatory menstrual cycles, polycystic ovary, hyperleptinemia, insulin resistance (IR), and cardiometabolic disorders, often associated with overweight or obesity and visceral adiposity. Recent Findings: The etiology and pathophysiology of PCOS are not yet fully understood, but insulin seems to play a key role in this disease. PCOS shares an inflammatory state with other chronic diseases such as obesity, type II diabetes, and cardiovascular diseases; however, recent studies have shown that a healthy nutritional approach can improve IR and metabolic and reproductive functions, representing a valid therapeutic strategy to ameliorate PCOS symptomatology. Summary: This review aimed to summarize and collect evidence about different nutritional approaches such as the Mediterranean diet (MedDiet) and the ketogenic diet (KD), as well as bariatric surgery and nutraceutical supplementation as probiotics, prebiotics, and synbiotics, among the others, used in patients with PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13668-023-00479-8

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 92

  1. Deans R. Polycystic ovary syndrome in adolescence. Med Sci. 2019;7:101.
  2. Driscoll DA. Polycystic ovary syndrome in adolescence. Semin Reprod Med. 2003;21:301–7. https://doi.org/10.1055/s-2003-43308. · DOI
  3. Kamangar F, Okhovat JP, Schmidt T, Beshay A, Pasch L, Cedars MI, et al. Polycystic ovary syndrome: special diagnostic and therapeutic considerations for children. Pediatr Dermatol. 2015;32:571–8. https://doi.org/10.1111/pde.12566. · DOI
  4. Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol 2022;151:103628. https://doi.org/10.1016/j.jri.2022.103628. · DOI
  5. Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7. https://doi.org/10.1093/humrep/deh098. · DOI · Paper page
  6. Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol. 2007;67:735–42. https://doi.org/10.1111/j.1365-2265.2007.02954.x. · DOI · Paper page
  7. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276–84. https://doi.org/10.1210/jc.2007-0425. · DOI · Paper page
  8. Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009;116:1633–9. https://doi.org/10.1111/j.1471-0528.2009.02347.x. · DOI · Paper page
  9. de Zegher F, Ibáñez L. Early origins of polycystic ovary syndrome: hypotheses may change without notice. J Clin Endocrinol Metab. 2009;94:3682–5. https://doi.org/10.1210/jc.2009-1608. · DOI · Paper page
  10. Legro RS, Driscoll D, Strauss JFIII, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95:14956–60. https://doi.org/10.1073/pnas.95.25.1495. · doi:10.1073/pnas.95.25.1495
  11. Escobar-Morreale HF, Luque-Ramírez M, San Millán JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26:251–82. https://doi.org/10.1210/er.2004-0004. · DOI · Paper page
  12. Yildiz BO, Goodarzi MO, Guo X, Rotter JI, Azziz R. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Fertil Steril. 2006;86:1688–93. https://doi.org/10.1016/j.fertnstert.2006.05.045. · DOI
  13. Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab. 2007;92:4191–8. https://doi.org/10.1210/jc.2007-0761. · DOI · Paper page
  14. Segars JH, Decherney AH. Is there a genetic basis for polycystic ovary syndrome? J Clin Endocrinol Metab. 2010;95:2058–60. https://doi.org/10.1210/jc.2010-0518. · DOI
  15. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92:240–5. https://doi.org/10.1210/jc.2006-1582. · DOI · Paper page
  16. Villarroel C, Merino PM, López P, Eyzaguirre FC, Van Velzen A, Iñiguez G, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod. 2011;26:2861–8. https://doi.org/10.1093/humrep/der223. · DOI
  17. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, et al. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362:1017–21. https://doi.org/10.1016/S0140-6736(03)14410-8. · DOI · Paper page
  18. Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:881–7. https://doi.org/10.1210/jc.2007-1650. · DOI · Paper page
  19. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800. https://doi.org/10.1210/er.18.6.774. · DOI · Paper page
  20. Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:328–37. https://doi.org/10.1210/jc.2006-1665. · DOI · Paper page
  21. Cortón M, Botella-Carretero JI, López JA, Camafeita E, San Millán JL, Escobar-Morreale HF, et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod. 2008;23:651–61. https://doi.org/10.1093/humrep/dem380. · DOI · Paper page
  22. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336–40. https://doi.org/10.1210/jc.2005-1696. · DOI · Paper page
  23. Victor VM, Rocha M, Bañuls C, Sanchez-Serrano M, Sola E, Gomez M, et al. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2009;94:3505–12. https://doi.org/10.1210/jc.2009-0466. · DOI
  24. Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents. Curr Opin Pediatr. 2019;31:562–9. · DOI · Paper page
  25. Dumitrescu R, Mehendintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovarian syndrome: an update on mechanical and hormonal mechanism. J Med Life. 2015;8:142–5.
  26. Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum Müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002;77(1):141–6. · DOI · Paper page
  27. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91:786–878. · DOI · Paper page
  28. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107–17. · DOI · Paper page
  29. Knight PGaG C. TGF-b superfamily members and ovarian follicle development. Reproduction. 2006;121:503-512. · DOI · Paper page
  30. Bea Y. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5558–62. · DOI
  31. Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni GE, Ciampaglia W, Pagotto U, Walker BR, Pasquali R 2009 Increased clearance of cortisol by 5beta reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J Endocrinol Invest. 2009;32:210–18. · DOI
  32. Bergman RN. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes. 2007;56:1489–501. · DOI · Paper page
  33. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30:586–623. · DOI · Paper page
  34. Kahn CR. The molecular mechanism of insulin action. Annu Rev Med. 1985;36:429–51. · DOI · Paper page
  35. Krishnan A, Muthusami S. Hormonal Alterations in PCOS and its influence on bone metabolism. J Endocrinol. 2017;232(2):R99–113. · DOI · Paper page
  36. Di Sarra D, Tosi F, Bonin C, Fiers T, Kaufman JM, Signori C, Zambotti F, Dall’Alda M, Caruso B, Zanolin ME, Bonora E, Moghetti P. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism. J Clin Endocrinol Metab. 2013;98:2581–8. · DOI
  37. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Ronsisvalle E, Guido M, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999;48:167–72. · DOI
  38. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008;23:153–9. · DOI · Paper page
  39. Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol. 2013;78(3):321–9. · DOI · Paper page
  40. Homburg R, Pariente C, Lunenfeld B, Jacobs HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod. 1992;7(10):1379–83. · DOI
  41. Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. Journal of Cli Endo Metabo. 1996;81:942–7.
  42. Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab. 2009;94:157–63. · DOI · Paper page
  43. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41:1257–66. · DOI · Paper page
  44. Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes. 2006;55:751–9. · DOI · Paper page
  45. Rajkhowa M, Brett S, Cuthbertson DJ, Lipina C, Ruiz-Alcaraz AJ, Thomas GE, Logie L, Petrie JR, Sutherland C. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Biochem J. 2009;418:665–71. · DOI · Paper page
  46. Annika KS, Sascha T, Olaf O. Insulin resistance in patients with polycystic ovary syndrome. Ann Med. 2004;36:426–39. · DOI · Paper page
  47. Ciaraldi TP. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab. 2000;13(Suppl 5):1291–3.
  48. Hansen SL, Svendsen PF, Jeppesen JF, Hoeg LD, Andersen NR, Kristensen JM, Nilas L, Lundsgaard AM, Wojtaszewski JFP, Madsbad S, Kiens B. Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104:1841–54. · DOI · Paper page
  49. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994;78:1052–8.
  50. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulinaemic clamp. Hum Reprod. 2013;28:777–84. · DOI · Paper page
  51. Attle AD, Schrer PE. Adipocyte metabolism and obesity. J Lipid Res. 2009;50(Suppl):S395-399. · DOI · Paper page
  52. Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes. 2012;61:2369–74. · DOI · Paper page
  53. Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, Trakakis E. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. J Am Acad Dermatol. 2013;69(6):922–30. https://doi.org/10.1016/j.jaad.2013.09.014. Epub 2013 Oct 11 PMID: 24120563. · DOI
  54. Zeind CS, Carvalho MG. Applied therapeutics: the clinical use of drugs; Wolters Kluwer Health: Philadelphia. USA: PA; 2017.
  55. •• Lei W, Yang gao MM, Shiruo Hu MD, Dongying Liu MM, Qui Chen MM. Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome. Medicine. 2020;99:30(e20696). In this review, the authors report the results of several studies showing that in addition to conventional PCOS therapies, the inositol and ALA combination could act as a promising and safe therapy for PCOS women improving IR and oxidative stress status. · DOI
  56. Szczuko M, Sankowska P, Zapałowska-Chwyć M, Wysokiński P. Studies on the quality nutrition in women with polycystic ovary syndrome (PCOS). Rocz Panstw Zakl Hig. 2017;68(1):61–7 PMID: 28303702.
  57. Chavarro J, Rich-Edwards J, Rosner B, et al. A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr. 2009;63:78–86. https://doi.org/10.1038/sj.ejcn.1602904. · DOI · Paper page
  58. Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020;10(1):7802. · DOI · Paper page
  59. Dalamaga M, Muscogiuri G, Paganitsa G, Parvouleskou G, Syriou V, Karagkoynis P, Stratigou T, Vallianou N, Christodoulatos GS, Karampela I, Daskalopoulou K. Adherence to the Mediterranean diet is an independent predictor of circulating vitamin D levels in normal weight and non-smoker adults: an observational cross-sectional study. Int J Food Sci Nutr. 2021;72(6):848–60. https://doi.org/10.1080/09637486.2021.1878488. Epub 2021 Jan 28 PMID: 33509003. · DOI
  60. Sikalidis AK, Kelleher AH, Kristo AS. Mediterranean diet. Encyclopedia. 2021;1(2):371–87. https://doi.org/10.3390/encyclopedia1020031. · DOI
  61. Chiurazzi M, Cacciapuoti N, Di Lauro M, Nasti G, Ceparano M, Salomone E, Guida B, Lonardo MS. The synergic effect of a nutraceutical supplementation associated to a mediterranean hypocaloric diet in a population of overweight/obese adults with NAFLD. Nutrients. 2022;14(22):4750. https://doi.org/10.3390/nu14224750. · DOI
  62. Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, et al. Healthy effects of plant polyphenols: molecular mechanisms. Int J Mol Sci. 2020;21(4):1250. · DOI · Paper page
  63. Verde L, Dalamaga M, Capó X, Annunziata G, Hassapidou M, Docimo A, Savastano S, Colao A, Muscogiuri G, Barrea L. The antioxidant potential of the mediterranean diet as a predictor of weight loss after a very low-calorie ketogenic diet (VLCKD) in women with overweight and obesity. Antioxidants (Basel). 2022;12(1):18. https://doi.org/10.3390/antiox12010018.PMID:36670880;PMCID:PMC9855093. · DOI
  64. Dowis K, Banga S. The potential health benefits of the ketogenic diet: a narrative review. Nutrients. 2021;13(5):1654. Published 2021 May 13. https://doi.org/10.3390/nu13051654. · DOI · Paper page
  65. Schugar RC, Crawford PA. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15(4):374–80. · DOI · Paper page
  66. Lee R, et al. A review of the impact of bariatric surgery in women with polycystic ovary syndrome. Cureus. 2020;12:10 e10811. https://doi.org/10.7759/cureus.10811. · DOI
  67. Ezzat RS, Abdallah W, Elsayed M, Saleh HS, Abdalla W. Impact of bariatric surgery on androgen profile and ovarian volume in obese polycystic ovary syndrome patients with infertility. Saudi J Biol Sci. 2021 Sep;28(9):5048–5052. https://doi.org/10.1016/j.sjbs.2021.05.022. Epub 2021 May 14. PMID: 34466081; PMCID: PMC8381004. · DOI
  68. •• Lili Hu, Ma Li, Xia X, Ying T, Zhou M, Zou S, Haoyong Yu, Yin J. Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(8):e3217–29. https://doi.org/10.1210/clinem/dgac294. This paper evaluates the difference in efficacy between drug and bariatric surgery therapy in 90 women with obesity and PCOS suggesting that bariatric surgery should be considered as the first-line treatment for patients with PCOS and obesity, being far more effective than drug therapy. · DOI
  69. Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional supplements and complementary therapies in polycystic ovary syndrome. Adv Nutr. 2022;13(4):1243–66. https://doi.org/10.1093/advances/nmab141.PMID:34970669;PMCID:PMC9340985. · DOI · Paper page
  70. Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, Nestler JE, Soulage CO. Inositols in polycystic ovary syndrome: an overview on the advances. Trends Endocrinol Metab. 2020;31:435–47. · DOI · Paper page
  71. Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12:1181–96. · DOI · Paper page
  72. Laganà AS, Monti N, Fedeli V, Gullo G, Bizzarri M. Does alpha-lipoic acid improve effects on polycystic ovary syndrome? Eur Rev Med Pharmacol. 2022;26(4):1241–7. https://doi.org/10.26355/eurrev_202202_28116. · DOI
  73. Monastra G, De Grazia S, Micili SC, Goker A, Unfer V. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in prevent miscarriage. Expert Opin Drug Deliv. 2016;13:1695–708. · DOI
  74. Genazzani AD, Prati A, Marchini F, Petrillo T, Napolitano A, Simoncini T. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome e patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecol Endocrinol. 2019;35:1088–93. · DOI
  75. Masharani U, Gjerde C, Evans JL, Youngren JF, Goldfine ID. Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2010;4(2):359–64. · DOI
  76. Fruzzetti F, Fidecicchi T, Palla G, Gambacciani M. Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. Gynecol Endocrinol. 2020;36:152–5. · DOI
  77. Genazzani AD, Shefer K, Della Casa D, Prati A, Napolitano A, Manzo A, Despini G, Simoncini T. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018;41:583–90. · DOI
  78. Cianci A, Panella M, Fichera M, Falduzzi C, Bartolo M, Caruso S. d-Chiro-inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecol Endocrinol. 2015;31(6):483–6. · DOI
  79. Miao C-Y, Fang X-J, Chen Y, Zhang Q. Effect of vitamin D supplementation on polycystic ovary syndrome: a meta-analysis. Exp Ther Med. 2020;19(4):2641–9.
  80. Guo S, Tal R, Jiang H, Yuan T, Liu Y. Vitamin D supplementation ameliorates metabolic dysfunction in patients with PCOS: a systematic review of RCTs and insight into the underlying mechanism. Int J Endocrinol. 2020;2020:1. · DOI · Paper page
  81. Gao H, Li Y, Yan W, Gao F. The effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome: a meta- analysis of randomized controlled trials. Int J Endocrinol. 2021;2021:1.
  82. Giampaolino P, Foreste V, Di Filippo C, Gallo A, Mercorio A, Serafino P, Improda FP, Verrazzo P, Zara G, Buonfantino CJ. Microbiome and PCOS: state-of-art and future aspects. Int J Mol Sci. 2021;22:2048. · DOI · Paper page
  83. Ahmadi S, Jamilian M, Karamali M, Tajabadi-Ebrahimi M, Jafari P, Taghizadeh M, Memarzadeh MR, Asemi Z. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil. 2017;20:254–61. · DOI · Paper page
  84. Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020;59:433–50. · DOI
  85. Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB. Effects of inulin-type fructans, galactooligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: a systematic review. Clin Nutr. 2017;36:1197–1206. · DOI
  86. Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019;58:629–40. · DOI
  87. Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol. 2015;52(12):7577–87. https://doi.org/10.1007/s13197-015-1921-1. · DOI · Paper page
  88. Cozzolino M, Vitagliano A, Pellegrini L, Chiurazzi M, Andriasani A, Ambrosini G, Garrido N. Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020 Oct;59(7):2841–2856. https://doi.org/10.1007/s00394-020-02233-0. Epub 2020 May 5. Erratum in: Eur J Nutr. 2022 Jun;61(4):2233–2235. PMID: 32372265 · DOI
  89. Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071–83. https://doi.org/10.1210/clinem/dgaa839. · DOI · Paper page
  90. Lyu X, Lyu T, Wang X, Zhu H, Pan H, Wang L, Yang H, Gong F. The antiobesity effect of GLP-1 receptor agonists alone or in combination with metformin in overweight/obese women with polycystic ovary syndrome: a systematic review and meta-analysis. International journal of endocrinology. 2021;2021:6616693. https://doi.org/10.1155/2021/6616693. · DOI
  91. Barr S, Hart K, Reeves S, Sharp K, Jeanes YM. Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome. Eur J Clin Nutr. 2011;65(10):1126–32. https://doi.org/10.1038/ejcn.2011.81. · DOI
  92. Che Y, Yu J, Li YS, Zhu YC, Tao T. Polycystic ovary syndrome: challenges and possible solutions. J Clin Med. 2023;12(4):1500. https://doi.org/10.3390/jcm12041500. · DOI

Cited by

See all 108

Metadata

Authors
Di Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M.
Venue
Current Nutrition Reports
Published
2023-05-22
Volume
12
Issue
3
Pages
527-544
ISSN
2161-3311 (ISSN-L)
OpenAlex
W4377220378
Cited by
108
References
50
FWCI
20.79
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
Università degli Studi di Napoli Federico II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. https://app.cochat.ai/papers/10.1007/s13668-023-00479-8
The paper
Di Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023). Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Current Nutrition Reports. https://doi.org/10.1007/s13668-023-00479-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.